From: Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung
 | All tumors | TC | AC | LCNEC |
---|---|---|---|---|
Clinical status at last f/u | Â | Â | Â | Â |
Alive without recurrence | 35 | 30 | 5 | 0 |
Alive with recurrence | 2 | 0 | 1 | 1 |
Alive, unknown | 7 | 6 | 0 | 1 |
Died with disease | 8 | 0 | 1 | 7 |
Died of other causes | 2 | 2 | 0 | 0 |
Died, unknown cause | 1 | 1 | 0 | 0 |
Median disease free survival (months) †| NR | NR | 35.5 | 10.1 |
Hazard ratio | Â | <0.01 | 0.10 | 1.00 |
Confidence interval (95%) | Â | - | 0.01-0.57 | - |
P-value | - | <0.0001 | 0.0063 | - |
Mean DFS follow-up (months) | 20.2 | 21.9 | 21.9 | 12.0 |
Median survival (months) | NR | NR | NR | 19.7 |
Hazard ratio | Â | 0.06 | 0.08 | 1.00 |
Confidence interval (95%) | Â | 0.01-0.24 | 0.00-0.54 | - |
P-value | - | <0.0001 | 0.0070 | - |
Mean OS follow-up (months) | 29.6 | 31.4 | 34.3 | 18.3 |